Results for tag: "Nesiritide"

Nesiritide is a recombinant form of human B-type natriuretic peptide (BNP) used to treat acute decompensated heart failure (ADHF). It is a vasodilator that works by relaxing the blood vessels, allowing the heart to pump more efficiently. It is administered intravenously and is typically used in combination with other medications to reduce symptoms of ADHF. Nesiritide is a relatively new drug, having been approved by the FDA in 2001. Nesiritide is used to treat ADHF, a condition in which the heart is unable to pump enough blood to meet the body's needs. It is typically used in combination with other medications, such as diuretics and ACE inhibitors, to reduce symptoms of ADHF. Nesiritide is generally well-tolerated and has been shown to improve symptoms of ADHF in clinical trials. The Nesiritide market is a growing segment of the cardiovascular drugs market. It is used to treat a wide range of conditions, including ADHF, and is generally well-tolerated. As the prevalence of cardiovascular diseases increases, the demand for Nesiritide is expected to grow. Some companies in the Nesiritide market include Pfizer, Novartis, and Amgen. Show Less Read more